Therapeutic efficacy of Boerhaavia diffusa (Linn.) root methanolic extract in attenuating streptozotocin-induced diabetes, diabetes-linked hyperlipidemia and oxidative-stress in rats Article Swipe
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.15419/bmrat.v6i7.556
Introduction: We have previously demonstrated that sequentially extracted methanolic fractions of Boerhaavia diffusa (Linn.) showed marked antioxidant, antidiabetic and oxidative-DNA damage protective properties in vitro. The present study was undertaken to evaluate the beneficial effects of B.diffusa (Linn.) methanolic root extract and its partially purified bioactive fraction on streptozotocin (STZ)-induced hyperglycemia and hyperlipidemia in rats. Methods: The diabetic rats were treated for fourteen weeks either with methanolic extract of B. diffusa root (D-MT1, D-MT2, and D-MT3 : doses of 50, 150, and 300 mg/rat/day, respectively), partially isolated bioactive fraction (DBT: 0.5 mg/rat/day), or glibenclamide (D-GT: 0.5 mg/rat/day). Results: The level of fasting blood glucose (FBG) and glycated hemoglobin (HbA1c) were significantly alleviated in D-MT- and D-BT treated groups after fourteen weeks of administration. Moreover, plasma lipid profile, free fatty acids (FFAs), phospholipids (PLs), HMG-CoA reductase (HMG-R) activity, conjugated diene (CD), lipid hydroperoxide (LOOH), and malondialdehyde (MDA) were also markedly ameliorate d in all treatment groups. In addition, the activity of antioxidant enzymes, e.g., superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (Gred), and glutathione-S-transferase (GST), were also significantly restored by D-MT — and D-BT — treated groups. Furthermore, histologically, all the unseemly features of nephropathy were extensively regressed and normalized by the administration of B. diffusa and its bioactive fraction. Conclusions: Our results demonstrate a strong antidiabetic and hypolipidemic impact of B. diffusa extract an ideal alternative therapeutic agent in the prevention and treatment of diabetes as well as diabetes-linked hyperlipidemia.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.15419/bmrat.v6i7.556
- http://www.bmrat.org/index.php/BMRAT/article/download/556/1117
- OA Status
- diamond
- Cited By
- 39
- References
- 41
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2962076438
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2962076438Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.15419/bmrat.v6i7.556Digital Object Identifier
- Title
-
Therapeutic efficacy of Boerhaavia diffusa (Linn.) root methanolic extract in attenuating streptozotocin-induced diabetes, diabetes-linked hyperlipidemia and oxidative-stress in ratsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-07-13Full publication date if available
- Authors
-
Firoz Akhter, Sahir Sultan Alvi, Parvej Ahmad, Danish Iqbal, Bader Alshehri, M. Salman KhanList of authors in order
- Landing page
-
https://doi.org/10.15419/bmrat.v6i7.556Publisher landing page
- PDF URL
-
https://www.bmrat.org/index.php/BMRAT/article/download/556/1117Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://www.bmrat.org/index.php/BMRAT/article/download/556/1117Direct OA link when available
- Concepts
-
Oxidative stress, Antioxidant, Streptozotocin, Hyperlipidemia, Glutathione peroxidase, Glibenclamide, Glutathione, Pharmacology, Malondialdehyde, Glutathione reductase, Superoxide dismutase, Diabetes mellitus, Traditional medicine, Chemistry, Lipid profile, Catalase, Medicine, Biochemistry, Endocrinology, EnzymeTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
39Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 4, 2023: 15, 2022: 6, 2021: 10, 2020: 4Per-year citation counts (last 5 years)
- References (count)
-
41Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2962076438 |
|---|---|
| doi | https://doi.org/10.15419/bmrat.v6i7.556 |
| ids.doi | https://doi.org/10.15419/bmrat.v6i7.556 |
| ids.mag | 2962076438 |
| ids.openalex | https://openalex.org/W2962076438 |
| fwci | 4.2109361 |
| type | article |
| title | Therapeutic efficacy of Boerhaavia diffusa (Linn.) root methanolic extract in attenuating streptozotocin-induced diabetes, diabetes-linked hyperlipidemia and oxidative-stress in rats |
| biblio.issue | 7 |
| biblio.volume | 6 |
| biblio.last_page | 3306 |
| biblio.first_page | 3293 |
| topics[0].id | https://openalex.org/T11140 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2712 |
| topics[0].subfield.display_name | Endocrinology, Diabetes and Metabolism |
| topics[0].display_name | Natural Antidiabetic Agents Studies |
| topics[1].id | https://openalex.org/T11142 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9994999766349792 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1308 |
| topics[1].subfield.display_name | Clinical Biochemistry |
| topics[1].display_name | Advanced Glycation End Products research |
| topics[2].id | https://openalex.org/T12915 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9979000091552734 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1303 |
| topics[2].subfield.display_name | Biochemistry |
| topics[2].display_name | Biochemical Acid Research Studies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776151105 |
| concepts[0].level | 2 |
| concepts[0].score | 0.7153758406639099 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q898814 |
| concepts[0].display_name | Oxidative stress |
| concepts[1].id | https://openalex.org/C2778004101 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6455940008163452 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q133948 |
| concepts[1].display_name | Antioxidant |
| concepts[2].id | https://openalex.org/C2779280383 |
| concepts[2].level | 3 |
| concepts[2].score | 0.624765157699585 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q257331 |
| concepts[2].display_name | Streptozotocin |
| concepts[3].id | https://openalex.org/C2779091943 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6022598743438721 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1079120 |
| concepts[3].display_name | Hyperlipidemia |
| concepts[4].id | https://openalex.org/C2778760513 |
| concepts[4].level | 4 |
| concepts[4].score | 0.5812220573425293 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q24773045 |
| concepts[4].display_name | Glutathione peroxidase |
| concepts[5].id | https://openalex.org/C2779768347 |
| concepts[5].level | 3 |
| concepts[5].score | 0.577285885810852 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q420626 |
| concepts[5].display_name | Glibenclamide |
| concepts[6].id | https://openalex.org/C538909803 |
| concepts[6].level | 3 |
| concepts[6].score | 0.5593377351760864 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q116907 |
| concepts[6].display_name | Glutathione |
| concepts[7].id | https://openalex.org/C98274493 |
| concepts[7].level | 1 |
| concepts[7].score | 0.5376298427581787 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[7].display_name | Pharmacology |
| concepts[8].id | https://openalex.org/C2778401633 |
| concepts[8].level | 3 |
| concepts[8].score | 0.5087226033210754 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q418661 |
| concepts[8].display_name | Malondialdehyde |
| concepts[9].id | https://openalex.org/C165069038 |
| concepts[9].level | 5 |
| concepts[9].score | 0.5029072165489197 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q420930 |
| concepts[9].display_name | Glutathione reductase |
| concepts[10].id | https://openalex.org/C2775838275 |
| concepts[10].level | 3 |
| concepts[10].score | 0.49782752990722656 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q410776 |
| concepts[10].display_name | Superoxide dismutase |
| concepts[11].id | https://openalex.org/C555293320 |
| concepts[11].level | 2 |
| concepts[11].score | 0.4881154000759125 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q12206 |
| concepts[11].display_name | Diabetes mellitus |
| concepts[12].id | https://openalex.org/C556039675 |
| concepts[12].level | 1 |
| concepts[12].score | 0.47131022810935974 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q771035 |
| concepts[12].display_name | Traditional medicine |
| concepts[13].id | https://openalex.org/C185592680 |
| concepts[13].level | 0 |
| concepts[13].score | 0.4540177583694458 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[13].display_name | Chemistry |
| concepts[14].id | https://openalex.org/C2778270857 |
| concepts[14].level | 3 |
| concepts[14].score | 0.41738444566726685 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q2723972 |
| concepts[14].display_name | Lipid profile |
| concepts[15].id | https://openalex.org/C2778979269 |
| concepts[15].level | 3 |
| concepts[15].score | 0.413303941488266 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q106951292 |
| concepts[15].display_name | Catalase |
| concepts[16].id | https://openalex.org/C71924100 |
| concepts[16].level | 0 |
| concepts[16].score | 0.37201184034347534 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[16].display_name | Medicine |
| concepts[17].id | https://openalex.org/C55493867 |
| concepts[17].level | 1 |
| concepts[17].score | 0.3445132374763489 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[17].display_name | Biochemistry |
| concepts[18].id | https://openalex.org/C134018914 |
| concepts[18].level | 1 |
| concepts[18].score | 0.281746506690979 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q162606 |
| concepts[18].display_name | Endocrinology |
| concepts[19].id | https://openalex.org/C181199279 |
| concepts[19].level | 2 |
| concepts[19].score | 0.21448388695716858 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q8047 |
| concepts[19].display_name | Enzyme |
| keywords[0].id | https://openalex.org/keywords/oxidative-stress |
| keywords[0].score | 0.7153758406639099 |
| keywords[0].display_name | Oxidative stress |
| keywords[1].id | https://openalex.org/keywords/antioxidant |
| keywords[1].score | 0.6455940008163452 |
| keywords[1].display_name | Antioxidant |
| keywords[2].id | https://openalex.org/keywords/streptozotocin |
| keywords[2].score | 0.624765157699585 |
| keywords[2].display_name | Streptozotocin |
| keywords[3].id | https://openalex.org/keywords/hyperlipidemia |
| keywords[3].score | 0.6022598743438721 |
| keywords[3].display_name | Hyperlipidemia |
| keywords[4].id | https://openalex.org/keywords/glutathione-peroxidase |
| keywords[4].score | 0.5812220573425293 |
| keywords[4].display_name | Glutathione peroxidase |
| keywords[5].id | https://openalex.org/keywords/glibenclamide |
| keywords[5].score | 0.577285885810852 |
| keywords[5].display_name | Glibenclamide |
| keywords[6].id | https://openalex.org/keywords/glutathione |
| keywords[6].score | 0.5593377351760864 |
| keywords[6].display_name | Glutathione |
| keywords[7].id | https://openalex.org/keywords/pharmacology |
| keywords[7].score | 0.5376298427581787 |
| keywords[7].display_name | Pharmacology |
| keywords[8].id | https://openalex.org/keywords/malondialdehyde |
| keywords[8].score | 0.5087226033210754 |
| keywords[8].display_name | Malondialdehyde |
| keywords[9].id | https://openalex.org/keywords/glutathione-reductase |
| keywords[9].score | 0.5029072165489197 |
| keywords[9].display_name | Glutathione reductase |
| keywords[10].id | https://openalex.org/keywords/superoxide-dismutase |
| keywords[10].score | 0.49782752990722656 |
| keywords[10].display_name | Superoxide dismutase |
| keywords[11].id | https://openalex.org/keywords/diabetes-mellitus |
| keywords[11].score | 0.4881154000759125 |
| keywords[11].display_name | Diabetes mellitus |
| keywords[12].id | https://openalex.org/keywords/traditional-medicine |
| keywords[12].score | 0.47131022810935974 |
| keywords[12].display_name | Traditional medicine |
| keywords[13].id | https://openalex.org/keywords/chemistry |
| keywords[13].score | 0.4540177583694458 |
| keywords[13].display_name | Chemistry |
| keywords[14].id | https://openalex.org/keywords/lipid-profile |
| keywords[14].score | 0.41738444566726685 |
| keywords[14].display_name | Lipid profile |
| keywords[15].id | https://openalex.org/keywords/catalase |
| keywords[15].score | 0.413303941488266 |
| keywords[15].display_name | Catalase |
| keywords[16].id | https://openalex.org/keywords/medicine |
| keywords[16].score | 0.37201184034347534 |
| keywords[16].display_name | Medicine |
| keywords[17].id | https://openalex.org/keywords/biochemistry |
| keywords[17].score | 0.3445132374763489 |
| keywords[17].display_name | Biochemistry |
| keywords[18].id | https://openalex.org/keywords/endocrinology |
| keywords[18].score | 0.281746506690979 |
| keywords[18].display_name | Endocrinology |
| keywords[19].id | https://openalex.org/keywords/enzyme |
| keywords[19].score | 0.21448388695716858 |
| keywords[19].display_name | Enzyme |
| language | en |
| locations[0].id | doi:10.15419/bmrat.v6i7.556 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2764802203 |
| locations[0].source.issn | 2198-4093 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2198-4093 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Biomedical Research and Therapy |
| locations[0].source.host_organization | |
| locations[0].source.host_organization_name | |
| locations[0].license | cc-by |
| locations[0].pdf_url | http://www.bmrat.org/index.php/BMRAT/article/download/556/1117 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Biomedical Research and Therapy |
| locations[0].landing_page_url | https://doi.org/10.15419/bmrat.v6i7.556 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5036410879 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8836-601X |
| authorships[0].author.display_name | Firoz Akhter |
| authorships[0].countries | IN, US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I146416000 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Pharmacology and Toxicology, Higuchi Biosciences Center, University of Kansas, KS, USA |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I189949046 |
| authorships[0].affiliations[1].raw_affiliation_string | IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[0].institutions[0].id | https://openalex.org/I189949046 |
| authorships[0].institutions[0].ror | https://ror.org/039zd5s34 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I189949046 |
| authorships[0].institutions[0].country_code | IN |
| authorships[0].institutions[0].display_name | Integral University |
| authorships[0].institutions[1].id | https://openalex.org/I146416000 |
| authorships[0].institutions[1].ror | https://ror.org/001tmjg57 |
| authorships[0].institutions[1].type | education |
| authorships[0].institutions[1].lineage | https://openalex.org/I146416000 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | University of Kansas |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Firoz Akhter |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Pharmacology and Toxicology, Higuchi Biosciences Center, University of Kansas, KS, USA, IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[1].author.id | https://openalex.org/A5000810438 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5650-748X |
| authorships[1].author.display_name | Sahir Sultan Alvi |
| authorships[1].countries | IN |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I189949046 |
| authorships[1].affiliations[0].raw_affiliation_string | IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[1].institutions[0].id | https://openalex.org/I189949046 |
| authorships[1].institutions[0].ror | https://ror.org/039zd5s34 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I189949046 |
| authorships[1].institutions[0].country_code | IN |
| authorships[1].institutions[0].display_name | Integral University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Sahir Sultan Alvi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[2].author.id | https://openalex.org/A5013048618 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3102-4369 |
| authorships[2].author.display_name | Parvej Ahmad |
| authorships[2].countries | IN |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I189949046 |
| authorships[2].affiliations[0].raw_affiliation_string | IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[2].institutions[0].id | https://openalex.org/I189949046 |
| authorships[2].institutions[0].ror | https://ror.org/039zd5s34 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I189949046 |
| authorships[2].institutions[0].country_code | IN |
| authorships[2].institutions[0].display_name | Integral University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Parvej Ahmad |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[3].author.id | https://openalex.org/A5012824786 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-3033-4226 |
| authorships[3].author.display_name | Danish Iqbal |
| authorships[3].countries | IN, SA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I189949046 |
| authorships[3].affiliations[0].raw_affiliation_string | IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I195631090 |
| authorships[3].affiliations[1].raw_affiliation_string | Department of Medical laboratory Sciences, College of Applied medical Sciences, Majmaah University, Al-majma'ah-11952, Saudi Arabia |
| authorships[3].institutions[0].id | https://openalex.org/I189949046 |
| authorships[3].institutions[0].ror | https://ror.org/039zd5s34 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I189949046 |
| authorships[3].institutions[0].country_code | IN |
| authorships[3].institutions[0].display_name | Integral University |
| authorships[3].institutions[1].id | https://openalex.org/I195631090 |
| authorships[3].institutions[1].ror | https://ror.org/01mcrnj60 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I195631090 |
| authorships[3].institutions[1].country_code | SA |
| authorships[3].institutions[1].display_name | Majmaah University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Danish Iqbal |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Medical laboratory Sciences, College of Applied medical Sciences, Majmaah University, Al-majma'ah-11952, Saudi Arabia, IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[4].author.id | https://openalex.org/A5048523025 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-2847-0106 |
| authorships[4].author.display_name | Bader Alshehri |
| authorships[4].countries | SA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I195631090 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Medical laboratory Sciences, College of Applied medical Sciences, Majmaah University, Al-majma'ah-11952, Saudi Arabia |
| authorships[4].institutions[0].id | https://openalex.org/I195631090 |
| authorships[4].institutions[0].ror | https://ror.org/01mcrnj60 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I195631090 |
| authorships[4].institutions[0].country_code | SA |
| authorships[4].institutions[0].display_name | Majmaah University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Bader Mohammed Alshehri |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Medical laboratory Sciences, College of Applied medical Sciences, Majmaah University, Al-majma'ah-11952, Saudi Arabia |
| authorships[5].author.id | https://openalex.org/A5073522682 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-9716-8165 |
| authorships[5].author.display_name | M. Salman Khan |
| authorships[5].countries | IN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I189949046 |
| authorships[5].affiliations[0].raw_affiliation_string | IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| authorships[5].institutions[0].id | https://openalex.org/I189949046 |
| authorships[5].institutions[0].ror | https://ror.org/039zd5s34 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I189949046 |
| authorships[5].institutions[0].country_code | IN |
| authorships[5].institutions[0].display_name | Integral University |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | M. Salman Khan |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | IIRC-5, Clinical Biochemistry & Natural Product Research Lab, Department of Biosciences, Integral University, Lucknow, 226026, U.P., India |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://www.bmrat.org/index.php/BMRAT/article/download/556/1117 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Therapeutic efficacy of Boerhaavia diffusa (Linn.) root methanolic extract in attenuating streptozotocin-induced diabetes, diabetes-linked hyperlipidemia and oxidative-stress in rats |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11140 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2712 |
| primary_topic.subfield.display_name | Endocrinology, Diabetes and Metabolism |
| primary_topic.display_name | Natural Antidiabetic Agents Studies |
| related_works | https://openalex.org/W2397078474, https://openalex.org/W2015300033, https://openalex.org/W1236621784, https://openalex.org/W2255245294, https://openalex.org/W4389027043, https://openalex.org/W3212126562, https://openalex.org/W4235288160, https://openalex.org/W4287107256, https://openalex.org/W2144009114, https://openalex.org/W2142373574 |
| cited_by_count | 39 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 4 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 15 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 6 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 10 |
| counts_by_year[4].year | 2020 |
| counts_by_year[4].cited_by_count | 4 |
| locations_count | 1 |
| best_oa_location.id | doi:10.15419/bmrat.v6i7.556 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764802203 |
| best_oa_location.source.issn | 2198-4093 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2198-4093 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Biomedical Research and Therapy |
| best_oa_location.source.host_organization | |
| best_oa_location.source.host_organization_name | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | http://www.bmrat.org/index.php/BMRAT/article/download/556/1117 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Biomedical Research and Therapy |
| best_oa_location.landing_page_url | https://doi.org/10.15419/bmrat.v6i7.556 |
| primary_location.id | doi:10.15419/bmrat.v6i7.556 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2764802203 |
| primary_location.source.issn | 2198-4093 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2198-4093 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Biomedical Research and Therapy |
| primary_location.source.host_organization | |
| primary_location.source.host_organization_name | |
| primary_location.license | cc-by |
| primary_location.pdf_url | http://www.bmrat.org/index.php/BMRAT/article/download/556/1117 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Biomedical Research and Therapy |
| primary_location.landing_page_url | https://doi.org/10.15419/bmrat.v6i7.556 |
| publication_date | 2019-07-13 |
| publication_year | 2019 |
| referenced_works | https://openalex.org/W2893354709, https://openalex.org/W2168261002, https://openalex.org/W2587073861, https://openalex.org/W2120293565, https://openalex.org/W2894488278, https://openalex.org/W2581920297, https://openalex.org/W2019227795, https://openalex.org/W2995705260, https://openalex.org/W1891714429, https://openalex.org/W2168526937, https://openalex.org/W1959115459, https://openalex.org/W2607363770, https://openalex.org/W1599342152, https://openalex.org/W1885679900, https://openalex.org/W2469828100, https://openalex.org/W2769052489, https://openalex.org/W1984789703, https://openalex.org/W2167543749, https://openalex.org/W2804210244, https://openalex.org/W1963799565, https://openalex.org/W2119089420, https://openalex.org/W1996406938, https://openalex.org/W1907276384, https://openalex.org/W2096795975, https://openalex.org/W2094341839, https://openalex.org/W2159272194, https://openalex.org/W2011683287, https://openalex.org/W1967030960, https://openalex.org/W1953209992, https://openalex.org/W1942583428, https://openalex.org/W2315758257, https://openalex.org/W2108250096, https://openalex.org/W1999647730, https://openalex.org/W2114941179, https://openalex.org/W2265031623, https://openalex.org/W1983310681, https://openalex.org/W1981146931, https://openalex.org/W2056066400, https://openalex.org/W2104005551, https://openalex.org/W2082000115, https://openalex.org/W2148048541 |
| referenced_works_count | 41 |
| abstract_inverted_index.: | 76 |
| abstract_inverted_index.a | 216 |
| abstract_inverted_index.d | 150 |
| abstract_inverted_index.B. | 69, 206, 223 |
| abstract_inverted_index.In | 155 |
| abstract_inverted_index.We | 1 |
| abstract_inverted_index.an | 226 |
| abstract_inverted_index.as | 238, 240 |
| abstract_inverted_index.by | 181, 202 |
| abstract_inverted_index.in | 23, 53, 112, 151, 231 |
| abstract_inverted_index.of | 10, 35, 68, 78, 100, 121, 159, 195, 205, 222, 236 |
| abstract_inverted_index.on | 47 |
| abstract_inverted_index.or | 92 |
| abstract_inverted_index.to | 30 |
| abstract_inverted_index.0.5 | 90, 95 |
| abstract_inverted_index.300 | 82 |
| abstract_inverted_index.50, | 79 |
| abstract_inverted_index.Our | 213 |
| abstract_inverted_index.The | 25, 56, 98 |
| abstract_inverted_index.all | 152, 191 |
| abstract_inverted_index.and | 18, 41, 51, 74, 81, 105, 114, 143, 174, 184, 200, 208, 219, 234 |
| abstract_inverted_index.for | 61 |
| abstract_inverted_index.its | 42, 209 |
| abstract_inverted_index.the | 32, 157, 192, 203, 232 |
| abstract_inverted_index.was | 28 |
| abstract_inverted_index.— | 183, 186 |
| abstract_inverted_index.150, | 80 |
| abstract_inverted_index.D-BT | 115, 185 |
| abstract_inverted_index.D-MT | 182 |
| abstract_inverted_index.also | 147, 178 |
| abstract_inverted_index.free | 127 |
| abstract_inverted_index.have | 2 |
| abstract_inverted_index.rats | 58 |
| abstract_inverted_index.root | 39, 71 |
| abstract_inverted_index.that | 5 |
| abstract_inverted_index.well | 239 |
| abstract_inverted_index.were | 59, 109, 146, 177, 197 |
| abstract_inverted_index.with | 65 |
| abstract_inverted_index.(CD), | 139 |
| abstract_inverted_index.(DBT: | 89 |
| abstract_inverted_index.(FBG) | 104 |
| abstract_inverted_index.(MDA) | 145 |
| abstract_inverted_index.D-MT- | 113 |
| abstract_inverted_index.D-MT3 | 75 |
| abstract_inverted_index.acids | 129 |
| abstract_inverted_index.after | 118 |
| abstract_inverted_index.agent | 230 |
| abstract_inverted_index.blood | 102 |
| abstract_inverted_index.diene | 138 |
| abstract_inverted_index.doses | 77 |
| abstract_inverted_index.e.g., | 162 |
| abstract_inverted_index.fatty | 128 |
| abstract_inverted_index.ideal | 227 |
| abstract_inverted_index.level | 99 |
| abstract_inverted_index.lipid | 125, 140 |
| abstract_inverted_index.rats. | 54 |
| abstract_inverted_index.study | 27 |
| abstract_inverted_index.weeks | 63, 120 |
| abstract_inverted_index.(CAT), | 167 |
| abstract_inverted_index.(D-GT: | 94 |
| abstract_inverted_index.(GPx), | 170 |
| abstract_inverted_index.(GST), | 176 |
| abstract_inverted_index.(PLs), | 132 |
| abstract_inverted_index.(SOD), | 165 |
| abstract_inverted_index.D-MT2, | 73 |
| abstract_inverted_index.damage | 20 |
| abstract_inverted_index.either | 64 |
| abstract_inverted_index.groups | 117 |
| abstract_inverted_index.impact | 221 |
| abstract_inverted_index.marked | 15 |
| abstract_inverted_index.plasma | 124 |
| abstract_inverted_index.showed | 14 |
| abstract_inverted_index.strong | 217 |
| abstract_inverted_index.vitro. | 24 |
| abstract_inverted_index.(D-MT1, | 72 |
| abstract_inverted_index.(FFAs), | 130 |
| abstract_inverted_index.(Gred), | 173 |
| abstract_inverted_index.(HMG-R) | 135 |
| abstract_inverted_index.(HbA1c) | 108 |
| abstract_inverted_index.(LOOH), | 142 |
| abstract_inverted_index.(Linn.) | 13, 37 |
| abstract_inverted_index.HMG-CoA | 133 |
| abstract_inverted_index.diffusa | 12, 70, 207, 224 |
| abstract_inverted_index.effects | 34 |
| abstract_inverted_index.extract | 40, 67, 225 |
| abstract_inverted_index.fasting | 101 |
| abstract_inverted_index.glucose | 103 |
| abstract_inverted_index.groups. | 154, 188 |
| abstract_inverted_index.present | 26 |
| abstract_inverted_index.results | 214 |
| abstract_inverted_index.treated | 60, 116, 187 |
| abstract_inverted_index.Methods: | 55 |
| abstract_inverted_index.Results: | 97 |
| abstract_inverted_index.activity | 158 |
| abstract_inverted_index.catalase | 166 |
| abstract_inverted_index.diabetes | 237 |
| abstract_inverted_index.diabetic | 57 |
| abstract_inverted_index.enzymes, | 161 |
| abstract_inverted_index.evaluate | 31 |
| abstract_inverted_index.features | 194 |
| abstract_inverted_index.fourteen | 62, 119 |
| abstract_inverted_index.fraction | 46, 88 |
| abstract_inverted_index.glycated | 106 |
| abstract_inverted_index.isolated | 86 |
| abstract_inverted_index.markedly | 148 |
| abstract_inverted_index.profile, | 126 |
| abstract_inverted_index.purified | 44 |
| abstract_inverted_index.restored | 180 |
| abstract_inverted_index.unseemly | 193 |
| abstract_inverted_index.B.diffusa | 36 |
| abstract_inverted_index.Moreover, | 123 |
| abstract_inverted_index.activity, | 136 |
| abstract_inverted_index.addition, | 156 |
| abstract_inverted_index.bioactive | 45, 87, 210 |
| abstract_inverted_index.dismutase | 164 |
| abstract_inverted_index.extracted | 7 |
| abstract_inverted_index.fraction. | 211 |
| abstract_inverted_index.fractions | 9 |
| abstract_inverted_index.partially | 43, 85 |
| abstract_inverted_index.reductase | 134, 172 |
| abstract_inverted_index.regressed | 199 |
| abstract_inverted_index.treatment | 153, 235 |
| abstract_inverted_index.Boerhaavia | 11 |
| abstract_inverted_index.alleviated | 111 |
| abstract_inverted_index.ameliorate | 149 |
| abstract_inverted_index.beneficial | 33 |
| abstract_inverted_index.conjugated | 137 |
| abstract_inverted_index.hemoglobin | 107 |
| abstract_inverted_index.methanolic | 8, 38, 66 |
| abstract_inverted_index.normalized | 201 |
| abstract_inverted_index.peroxidase | 169 |
| abstract_inverted_index.prevention | 233 |
| abstract_inverted_index.previously | 3 |
| abstract_inverted_index.properties | 22 |
| abstract_inverted_index.protective | 21 |
| abstract_inverted_index.superoxide | 163 |
| abstract_inverted_index.undertaken | 29 |
| abstract_inverted_index.alternative | 228 |
| abstract_inverted_index.antioxidant | 160 |
| abstract_inverted_index.demonstrate | 215 |
| abstract_inverted_index.extensively | 198 |
| abstract_inverted_index.glutathione | 168, 171 |
| abstract_inverted_index.mg/rat/day, | 83 |
| abstract_inverted_index.nephropathy | 196 |
| abstract_inverted_index.therapeutic | 229 |
| abstract_inverted_index.Conclusions: | 212 |
| abstract_inverted_index.Furthermore, | 189 |
| abstract_inverted_index.antidiabetic | 17, 218 |
| abstract_inverted_index.antioxidant, | 16 |
| abstract_inverted_index.demonstrated | 4 |
| abstract_inverted_index.mg/rat/day), | 91 |
| abstract_inverted_index.mg/rat/day). | 96 |
| abstract_inverted_index.sequentially | 6 |
| abstract_inverted_index.(STZ)-induced | 49 |
| abstract_inverted_index.Introduction: | 0 |
| abstract_inverted_index.glibenclamide | 93 |
| abstract_inverted_index.hydroperoxide | 141 |
| abstract_inverted_index.hyperglycemia | 50 |
| abstract_inverted_index.hypolipidemic | 220 |
| abstract_inverted_index.oxidative-DNA | 19 |
| abstract_inverted_index.phospholipids | 131 |
| abstract_inverted_index.significantly | 110, 179 |
| abstract_inverted_index.administration | 204 |
| abstract_inverted_index.hyperlipidemia | 52 |
| abstract_inverted_index.respectively), | 84 |
| abstract_inverted_index.streptozotocin | 48 |
| abstract_inverted_index.administration. | 122 |
| abstract_inverted_index.diabetes-linked | 241 |
| abstract_inverted_index.histologically, | 190 |
| abstract_inverted_index.hyperlipidemia. | 242 |
| abstract_inverted_index.malondialdehyde | 144 |
| abstract_inverted_index.glutathione-S-transferase | 175 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 97 |
| corresponding_author_ids | https://openalex.org/A5073522682 |
| countries_distinct_count | 3 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I189949046 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6800000071525574 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.92541081 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |